Intestinal Microsporidiosis in French Heart Transplant Recipients (CARMIC)
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorUniversity Hospital, Clermont-Ferrand
About this trial
The investigators propose to carry out a national retrospective study to collect epidemiological, biological, clinical and therapeutic data on microsporidiosis among heart transplant patients.
Eligibility criteria
Qualifiers
heart transplant patients diagnosed with intestinal microsporidiosis
diagnosis made before December 31, 2024 in France (metropolitan France and overseas territories)
Disqualifiers
None
Trial design
Treatments tested in this trial
- Not listed
Trial groups
No trial groups listed
Sponsors and collaborators
Source ClinicalTrials.gov